|
| |
 |
OXFORD GENE TECHNOLOGY GRANTS MICROARRAY
LICENSE TO AUSHON BIOSYSTEMS |
Oxford, June 12, 2007 - Oxford Gene Technology (OGT) and Aushon
BioSystems are pleased to announce the completion of a licence
agreement granting Aushon access to OGT’s “Southern array patents”,
the fundamental patents covering the manufacture and marketing of
oligonucleotide microarrays.
The granted license will enable Aushon BioSystems to manufacture and
sell oligonucleotide microarrays, worldwide, and to perform services
based on oligonucleotide arrays.
Sue Sutton, Vice President Licensing North America, at OGT said:
“Successful discussions with Aushon have concluded with the granting
of this license. This will enable them to extend their current
offering to provide a range of microarray products to the market.”
John Austin, President and Co-Founder at Aushon BioSystems added:
“This agreement will enable Aushon to provide high quality, flexible
and affordable oligonucleotide microarray products to our customers
in life science research, drug discovery/development, and clinical
diagnostics”.
The licence will remain valid for the patents’ lifetime. Financial
details were not disclosed.
- ENDS -
For further information, please contact:
At Oxford Gene Technology:
Nicola Booton-Mander, Marketing Manager
Oxford Gene Technology
Begbroke Science Park
Sandy Lane, Yarnton
Oxford OX5 1PF
T: +44 1865 856352
F: +44 1865 842116
E: licensing@ogt.co.uk
W: www.ogt.co.uk
At Aushon BioSystems:
Mike Tognotti, VP Sales and Marketing
Aushon BioSystems Inc.
25 Adams Street
Burlington
MA 01803
T: 781-750-8664 ext. 224
F: 781-750-8733
E: mike.tognotti@aushon.com
W: www.aushon.com
Media Enquiries:
Annabel Entress, 0207 268 3002 /
a.entress@northbankcommunications.com
Sarah Jeffery, 0207 268 3002 /
s.jeffery@northbankcommunications.com
Notes to editors
About Oxford Gene Technology
Founded in 1995 by the pioneer of Southern Blotting, Professor Sir
Edwin Southern, OGT operates out of Begbroke Business Park near
Oxford, with excellent access to a growing network of life science
companies
OGT offers a comprehensive custom microarray consultancy service,
from experimental design through all stages to data analysis and
interpretation. It has a strong proven track record in providing
custom microarray service in a range of applications, and recently
announced the launch of its first microarray product, an Escherichia
coli K12 ChIP on chip, the first ChIP microarray product to be
launched as part of OGT’s Prokaryotic Chip2 family
The key focus areas of OGT include:
1. Array-based application products and services for life science
research and molecular diagnostics. OGT’s flexible and
cost-effective, customised DNA microarray service covers a range of
applications, offering specialist support and assisting customers
with every aspect of their research, from initial consultation and
experimental design to probe selection, array design and fabrication
through to data analysis and interpretation
2. Development of innovative platform products for clinical research
and diagnostics
3. Licensing. OGT operates an open licensing policy which has
successfully provided access for a number of companies to OGT's
fundamental intellectual property, particularly in the area of
microarrays
4. Scientific collaborations to generate diagnostic biomarker
intellectual property
For further information on OGT visit
http://www.ogt.co.uk/
About Aushon Biosystems
Aushon BioSystems provides advanced microarray products, instruments
and services for life-science research, drug discovery/development
and clinical diagnostics. The Company's proprietary 2470 Arrayer -
now used in leading research centers around the world - enables
researchers in the life science and pharmaceutical industries to
create high quality arrays ranging from DNA to lysates. Aushon
BioSystems is a privately held company based in Burlington, MA.
For further information on Aushon please visit the company’s website
at http://www.aushon.com
|
|
| |
|
